Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Mandal, Mahitosh  [Clear All Filters]
Journal Article
B Kumar D, Krishnakumar K, Jaganathan SKumar, Mandal M. Effect of Mangiferin and Mahanimbine on Glucose Utilization in 3T3-L1 cells. Pharmacogn Mag. 2013;9(33):72-5.
Biswas A, Rajesh Y, Mitra P, Mandal M. ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors. Biochim Biophys Acta Rev Cancer. 2020:188389.
Pradhan R, Chatterjee S, Hembram KChandra, Sethy C, Mandal M, Kundu CNath. Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages. J Nutr Biochem. 2021:108624.
Deepak K, Roy PKumar, Kola P, Mukherjee B, Mandal M. An overview of kinin mediated events in cancer progression and therapeutic applications. Biochim Biophys Acta Rev Cancer. 2022:188807.
Pradhan R, Paul S, Das B, Sinha S, Dash SRanjan, Mandal M, Kundu CNath. Resveratrol Nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6 dependent pathway. J Nutr Biochem. 2022:109257.
Jena BChandra, Sarkar S, Rout L, Mandal M. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance. Cancer Lett. 2021.
Dey A, Kundu M, Das S, Jena BChandra, Mandal M. Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer. Biochim Biophys Acta Rev Cancer. 2022:188692.